Announced
Completed
Financials
Tags
Sweden
Single Bidder
Completed
biotechnology company
Private
Acquisition
Cross Border
Majority
Biotechnology
Friendly
Synopsis
10x Genomics, an American biotechnology company, completed the acquisition of CartaNA, a Swedish biotechnology company, for $41m. "Our team has been focused on developing In Situ technologies for a number of years, starting with work at Stockholm University and Karolinska Institute. We are thrilled to join 10x and become a part of their Swedish research center in Stockholm as we continue to build and deliver products for scientists around the globe," Malte Kuhnemund, CartaNA co-founder and EVP of R&D.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.